NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Eurofins-Cerep SA (PA: ALECR)
ALECR Technical Analysis
5
As on 16th Feb 2023 ALECR STOCK Price closed @ 22200.00 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 15750.64 & Strong Buy for SHORT-TERM with Stoploss of 14032.73 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALECRSTOCK Price
Open | 22200.00 | Change | Price | % |
High | 22200.00 | 1 Day | 0.00 | 0.00 |
Low | 22200.00 | 1 Week | 0.00 | 0.00 |
Close | 22200.00 | 1 Month | 0.00 | 0.00 |
Volume | N/A | 1 Year | 8600.00 | 63.24 |
52 Week High 22600.00 | 52 Week Low 13100.00 |
PA France Most Active Stocks
FTI | 5.91 | -1.66% |
VIEDS | 0.72 | 4.35% |
LAT | 0.01 | 0.00% |
ATO | 0.74 | -17.78% |
ACA | 12.56 | -0.87% |
ORA | 10.01 | -0.79% |
ENGI | 14.96 | -0.86% |
CS | 32.54 | -1.33% |
CA | 13.71 | -4.79% |
ALNRG | 0.01 | 0.00% |
PA France Top Gainers Stocks
PA France Top Losers Stocks
ALECR Daily Charts |
ALECR Intraday Charts |
Whats New @ Bazaartrend |
ALECR Free Analysis |
|
ALECR Important Levels Intraday
RESISTANCE | 22200.00 |
RESISTANCE | 22200.00 |
RESISTANCE | 22200.00 |
RESISTANCE | 22200.00 |
RESISTANCE | 22200.00 |
RESISTANCE | 22200.00 |
RESISTANCE | 22200.00 |
RESISTANCE | 22200.00 |
ALECR Forecast December 2024
4th UP Forecast | 23741.6 |
3rd UP Forecast | 23247.2 |
2nd UP Forecast | 22941.6 |
1st UP Forecast | 22636 |
1st DOWN Forecast | 21764 |
2nd DOWN Forecast | 21458.4 |
3rd DOWN Forecast | 21152.8 |
4th DOWN Forecast | 20658.4 |
ALECR Weekly Forecast
4th UP Forecast | 23741.60 |
3rd UP Forecast | 23247.20 |
2nd UP Forecast | 22941.60 |
1st UP Forecast | 22636.00 |
1st DOWN Forecast | 21764.00 |
2nd DOWN Forecast | 21458.40 |
3rd DOWN Forecast | 21152.80 |
4th DOWN Forecast | 20658.40 |
ALECR Forecast2024
4th UP Forecast | 40506.5 |
3rd UP Forecast | 34635.5 |
2nd UP Forecast | 31006.5 |
1st UP Forecast | 27377.5 |
1st DOWN Forecast | 17022.5 |
2nd DOWN Forecast | 13393.5 |
3rd DOWN Forecast | 9764.5 |
4th DOWN Forecast | 3893.5 |
Eurofins-Cerep SA ( PA France Symbol : ALECR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALECR Other Details
Segment | EQ | |
Market Capital | 90287600.00 | |
Sector | Healthcare | |
Industry | Drug Manufacturers-General | |
Offical website | > echo $website ; ?> |
ALECR Address
ALECR Latest News
ALECR Business Profile
Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France. Address: Le Bois l'Evêque, Vienne, France, 86600
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service